Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging

PHASE4UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

August 8, 2022

Study Completion Date

August 8, 2022

Conditions
PsoriasisPsoriatic ArthritisPsoriatic Nail
Interventions
DRUG

Etanercept

TNF-alpha inhibitors improve nail psoriasis.

DEVICE

OCT

Optical Coherence Tomography is a noninvasive imaging device that can be used to monitor nail disease severity.

Trial Locations (1)

10128

RECRUITING

OptiSkin Medical, New York

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

OptiSkin Medical

OTHER

NCT05135312 - Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging | Biotech Hunter | Biotech Hunter